Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 23391271)

1.

Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.

Ruiz M, Hedman E, Gåfvels M, Eggertsen G, Werner S, Wahrenberg H, Wikström AC.

Scand J Clin Lab Invest. 2013 Apr;73(3):203-7. doi: 10.3109/00365513.2013.764573. Epub 2013 Feb 8.

PMID:
23391271
2.

Another step in understanding glucocorticoid resistance in critical illness.

Branco RG, Garcia PC, Tasker RC.

Pediatr Crit Care Med. 2015 Jun;16(5):489-90. doi: 10.1097/PCC.0000000000000421. No abstract available.

PMID:
26039432
3.

A Novel Mutation of the hGR Gene Causing Chrousos Syndrome.

Nicolaides NC, Geer EB, Vlachakis D, Roberts ML, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E.

Eur J Clin Invest. 2015 May 29. doi: 10.1111/eci.12470. [Epub ahead of print]

PMID:
26031419
4.

Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome.

Nicolaides NC, Kino T, Chrousos G, Charmandari E.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2014 Dec 22.

5.

Chrousos syndrome: from molecular pathogenesis to therapeutic management.

Nicolaides NC, Charmandari E.

Eur J Clin Invest. 2015 May;45(5):504-14. doi: 10.1111/eci.12426. Epub 2015 Mar 23.

PMID:
25715669
6.

A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.

Banuelos J, Shin SC, Lu NZ.

Steroids. 2015 Apr;96:115-20. doi: 10.1016/j.steroids.2015.01.022. Epub 2015 Feb 9.

PMID:
25676786
7.

Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK.

Yang N, Caratti G, Ince LM, Poolman TM, Trebble PJ, Holt CM, Ray DW, Matthews LC.

J Endocrinol. 2014 Nov;223(2):155-66. doi: 10.1530/JOE-14-0456. Epub 2014 Aug 26.

8.

Historical contingency and its biophysical basis in glucocorticoid receptor evolution.

Harms MJ, Thornton JW.

Nature. 2014 Aug 14;512(7513):203-7. doi: 10.1038/nature13410. Epub 2014 Jun 15.

9.

Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling.

Henley DE, Lightman SL.

Clin Endocrinol (Oxf). 2014 May;80(5):621-8. doi: 10.1111/cen.12422. Epub 2014 Feb 25. Review.

PMID:
24611992
10.

The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer.

Jangani M, Poolman TM, Matthews L, Yang N, Farrow SN, Berry A, Hanley N, Williamson AJ, Whetton AD, Donn R, Ray DW.

J Biol Chem. 2014 Mar 28;289(13):8931-46. doi: 10.1074/jbc.M113.540906. Epub 2014 Jan 31.

11.

A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.

Nicolaides NC, Roberts ML, Kino T, Braatvedt G, Hurt DE, Katsantoni E, Sertedaki A, Chrousos GP, Charmandari E.

J Clin Endocrinol Metab. 2014 May;99(5):E902-7. doi: 10.1210/jc.2013-3005. Epub 2014 Jan 31.

12.

Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome.

Che R, Zhang A.

Kidney Blood Press Res. 2013;37(4-5):360-78. doi: 10.1159/000350163. Epub 2013 Sep 24. Review. No abstract available.

PMID:
24247120
13.

Coexistence of glucocorticoid resistance and pseudohypoparathyroidism.

Krysiak R, Kedzia A, Okopień B.

West Indian Med J. 2012 Dec;61(9):928-31.

PMID:
24020237
14.

Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome.

Swierczewska M, Ostalska-Nowicka D, Kempisty B, Nowicki M, Zabel M.

Acta Biochim Pol. 2013;60(3):339-44. Epub 2013 Aug 1. Review.

15.

Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor.

Capelli AM, Bruno A, Entrena Guadix A, Costantino G.

J Med Chem. 2013 Sep 12;56(17):7003-14. doi: 10.1021/jm400802b. Epub 2013 Aug 23.

PMID:
23927519
16.

A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.

Roberts ML, Kino T, Nicolaides NC, Hurt DE, Katsantoni E, Sertedaki A, Komianou F, Kassiou K, Chrousos GP, Charmandari E.

J Clin Endocrinol Metab. 2013 Apr;98(4):E790-5. doi: 10.1210/jc.2012-3549. Epub 2013 Feb 20.

17.

Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.

Charmandari E, Kino T, Chrousos GP.

Endocr Dev. 2013;24:67-85. doi: 10.1159/000342505. Epub 2013 Feb 1. Review.

18.

Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.

Ramamoorthy S, Cidlowski JA.

Endocr Dev. 2013;24:41-56. doi: 10.1159/000342502. Epub 2013 Feb 1. Review.

PMID:
23392094
19.

Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.

Donner KM, Hiltunen TP, Jänne OA, Sane T, Kontula K.

Eur J Endocrinol. 2012 Dec 10;168(1):K9-K18. doi: 10.1530/EJE-12-0532. Print 2013 Jan.

20.

An affective disorder in zebrafish with mutation of the glucocorticoid receptor.

Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA, Schaaf MJ, Yamamoto KR, Baier H.

Mol Psychiatry. 2013 Jun;18(6):681-91. doi: 10.1038/mp.2012.64. Epub 2012 May 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk